Initiate with ‘buy’ on Alkem Lab; target price Rs 3,315

on
Alkem boasts best-in-class domestic anti-infectives portfolio and leadership in multiple GI and vitamin sub-therapies. Its Chronic base is small, but growing at 18-20%.

from The Financial Express https://ift.tt/3cnuAQF
https://ift.tt/eA8V8J Edelweiss

Comments

Post a Comment